TPG:ASXTPG Telecom Limited Analysis
Data as of 2026-05-25 - not real-time
A$4.08
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
TPG trades at AUD 4.08, sitting below its 20‑day (4.16) and 50‑day (4.14) simple moving averages, with a bearish MACD histogram and an RSI of 41, indicating short‑term momentum weakness. Volume is rising, suggesting that sellers may be gaining traction. The stock’s trailing P/E of 136 is far above the industry average of 17, reflecting earnings compression, while the forward P/E remains elevated at 47. Despite this, the dividend yield of 4.41 % and a tiny payout ratio of 6.5 % point to a highly sustainable income stream. The DCF model places fair value at about AUD 5.42, implying only a modest ~2 % upside from current levels. Recent headlines about a stalled Singapore expansion bid add a material negative catalyst to the mix.
On the balance sheet, TPG carries heavy debt (≈A$4.15 bn) against modest cash reserves, yielding a debt‑to‑equity ratio near 48 % and limiting financial flexibility. However, its gross margin of 46 % and operating cash flow of A$2.42 bn provide a cushion for dividend continuity. The company’s low beta (0.74) and 30‑day volatility of 15.6 % suggest limited price swings relative to the market. With the market sentiment currently in “Extreme Greed” territory, investors may be underpricing the long‑run value implied by the sub‑1.0 price‑to‑book multiple. Overall, the technical picture is bearish in the near term, but the valuation and dividend profile remain attractive for patient holders.
On the balance sheet, TPG carries heavy debt (≈A$4.15 bn) against modest cash reserves, yielding a debt‑to‑equity ratio near 48 % and limiting financial flexibility. However, its gross margin of 46 % and operating cash flow of A$2.42 bn provide a cushion for dividend continuity. The company’s low beta (0.74) and 30‑day volatility of 15.6 % suggest limited price swings relative to the market. With the market sentiment currently in “Extreme Greed” territory, investors may be underpricing the long‑run value implied by the sub‑1.0 price‑to‑book multiple. Overall, the technical picture is bearish in the near term, but the valuation and dividend profile remain attractive for patient holders.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Bearish MACD and price below short‑term SMAs
- Negative news on Singapore expansion
- Increasing volume supporting downside pressure
Medium Term
1–3 yearsNeutral
Model confidence: 5/10
Key Factors
- High dividend yield with low payout ratio
- DCF fair‑value upside of ~2 %
- Stable operating cash flow despite leverage
Long Term
> 3 yearsPositive
Model confidence: 7/10
Key Factors
- Sub‑1.0 price‑to‑book indicating value
- Strong market position as second‑largest Australian telco
- Potential debt reduction and network synergies over time
Key Metrics & Analysis
Financial Health
Revenue Growth3.80%
Profit Margin9.13%
P/E Ratio136.0
ROE0.52%
ROA1.52%
Debt/Equity47.91
P/B Ratio0.9
Op. Cash FlowA$2.4B
Free Cash FlowA$960.2M
Industry P/E17.0
Technical Analysis
TrendNeutral
RSI41.3
SupportA$4.03
ResistanceA$4.31
MA 20A$4.16
MA 50A$4.14
MA 200A$4.41
MACDBearish
VolumeIncreasing
Fear & Greed Index91.8
Valuation
Fair ValueA$5.42
Target PriceA$4.16
Upside/Downside1.92%
GradeFair
TypeValue
Dividend Yield4.41%
Risk Assessment
Beta0.74
Volatility15.61%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.